David Ross Parkinson insider trades

Open-market stock purchases and sales by David Ross Parkinson, President and CEO at ESSA Pharma Inc, from SEC Form 4 filings since Apr 20, 2010.

Track record: 0% of 4 scored buys are up 5% or more since purchase, averaging -92%.

Recent trades

DateStockTradeValue
Oct 9, 2025EPIX ESSA Pharma IncSold (not open market)—

Companies traded

  • EPIX ESSA Pharma Inc: 4 buys, last Oct 9, 2025
  • CTIC CTI Biopharma Corp: other filings, last Jun 26, 2023
  • TOCA Tocagen Inc: other filings, last Oct 4, 2019
  • CERU Cerulean Pharma Inc: other filings, last Jan 3, 2017
  • THLD Threshold Pharmaceuticals Inc: other filings, last Jun 24, 2016
  • AMBI Ambit Biosciences Corp: other filings, last Nov 10, 2014
  • FACT Facet Biotech Corp: other filings, last Apr 21, 2010

Get free alerts when David Ross Parkinson files a new trade →